Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    cerulean
Show Display Options
Rank Status Study
1 Active, not recruiting CRLX101 Plus Bevacizumab in Advanced RCC
Condition: Renal Cell Carcinoma
Interventions: Drug: CRLX101 (Cerulean);   Drug: Bevacizumab
2 Completed A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: CRLX101;   Other: Best Supportive Care
3 Active, not recruiting Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: CRLX101;   Drug: Capecitabine;   Radiation: Radiotherapy;   Procedure: Surgery

Study has passed its completion date and status has not been verified in more than two years.